1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SETMAR CTRPv2 pan-cancer AAC 0.21 5e-09
mRNA C7orf26 CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA ZBTB5 CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA DOPEY1 CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA ALMS1 CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA SOX4 CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA ZNF618 CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA BAHCC1 CTRPv2 pan-cancer AAC 0.19 6e-09
mRNA TARBP1 CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA TRIM13 CTRPv2 pan-cancer AAC 0.2 6e-09
Download CSV